Brooklyn, New York, Aug. 24, 2022 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global MHC Multimers Market is projected to grow at a CAGR value of 4.8% from 2022 to 2027.
The growing investment in the development of novel gene therapy-based cancer treatments, the growing availability of cell therapy in the market, the growing investment in T-cell therapies, and technological advancements in immunodiagnostic technologies are the major drivers of the MHC multimers market.
Browse 155 Market Data Tables and 133 Figures spread through 156 Pages and in-depth TOC on “Global MHC Multimers Market - Forecast to 2027’’
Key Market Insights
- As per the product type outlook, the classical MHC multimers segment is expected to be the largest segment in the MHC multimers market from 2022 to 2027
- The Asia Pacific region is analyzed to be the fastest-growing segment in the market
- As per the application outlook, the therapeutic application segment is expected to be the fastest-growing segment in the MHC multimers market from 2022 to 2027
- North America (the United States, Canada, and Mexico) will have a dominant share in the global MHC multimers market from 2022 to 2027
- Immudex, Sigma-Aldrich, JPT Peptide Technologies, Creative Biolabs, ProImmune, MBL International, BioLegend, Altor BioScience Corporation, Immunaware, Bio X Cell, and Sanquin, among others, are the some of the key players in the MHC multimers market
Request a Sample Copy of the Report @ https://www.globalmarketestimates.com/market-report/mhc-multimers-market-3893
Regional Outlook (Revenue, USD Billion, 2022-2027)
North America
- The U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Netherlands
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Thailand
- Indonesia
- Malaysia
- Singapore
- Vietnam
- Rest of APAC
Central & South America
- Brazil
- Argentina
- Chile
- Rest of CSA
Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of MEA
Contact: Yash Jain
Email address: yash.jain@globalmarketestimates.com
Phone Number: +1 6026667238
